Pathway's power to boost, halt tumors may be promising cancer therapy target
A protein, called inositol-requiring enzyme 1—IRE1—may serve as a key driver in a series of molecular interactions that can both promote and, paradoxically, inhibit tumors in certain types of cancers, such as non-melanoma ...
Aug 29, 2017
0
5